Hopp til hovedinnholdet

Publications

NIBIOs employees contribute to several hundred scientific articles and research reports every year. You can browse or search in our collection which contains references and links to these publications as well as other research and dissemination activities. The collection is continously updated with new and historical material.

2023

To document

Abstract

This report is a documentation of the field data collection and sampling at Svalbard in 2022 within the project ArcticAlpineDecay. The sampling methods are described and for each object sampling was performed documentation is provided, incl. location, Askeladden ID, map coordinate, photo documentation and illustration of sampling. Compilation of the results from the project will be published in peer review journals and in a final report from the project.

To document

Abstract

Despite newly approved lucerne cultivars, this has not led to increased use of this legume in high-latitude agriculture. Challenges with inoculation by Rhizobium meliloti have been identified as a bottleneck to adaptation. Here we tested inoculation sources (ISs) with soil types and cultivars in pot and field experiments. During a one-year outdoor pot experiment, we tested the impact of IS (wet peat slurry and Nitragin Gold dry inoculation) and three soil types (sand, sandy silt and /peat soil) on nodule development, shoot and root growth and winter survival of one hybrid lucerne cultivar (‘Ludvig’). The pot experiment revealed that dry inoculation led to significant better plant growth, flower and nodule development as well as plant regrowth after winter survival. Peat soil appeared as the best growth medium and silty soil limited inoculation efficiencies. In field trials at two locations differing in soil characteristics using similar ISs, and three hybrid lucerne cultivars (‘Lavo’, ‘Live’ and ‘Lotte’) biomass yield during two ley years showed site as well as cultivar differences. Such environmental interactions in the field trials justify the use of adapted cultivars, and dry inoculation should be recommended for practical use replacing peat slurry inoculation.

To document

Abstract

The objective of SCANGREEN 2019-22 was to find species, varieties and seed blends/mixtures of Agrostis, Festuca, Poa and Lolium that are suited for pesticide-free management of putting greens in the two major climatic zones of the Nordic countries and in the northern USA. The four test sites in the Nordic countries were Reykjavik GC, Iceland and NIBIO Apelsvoll in the the northern zone, and NIBIO Landvik, Norway and Smørum GC, Denmark in the southern zone. The two US test sites were located at Troll Turfgrass Research Facility in Massachusetts and at University of Minnesota. The trials included 30 candidate varieties representing eight different species and subspecies from 13 different seed companies/representatives, and three seed mixtures of red fescue and colonial and creeping bentgrass, a seed mixture of creeping bentgrass and perennial ryegrass and a seed blend of red fescue. Monthly evaluations of overall impression, tiller density, winter hardiness, disease and weed coverage etc., were done from three weeks after sowing in June-September 2019 until October 2022. The trial at Smørum GC was established in May 2021. The trials were established according to a split-plot design with three blocks (replicates), species on main plots and varieties on subplots. The experimental greens were mown three times per week – Monday, Wednesday, and Friday and deficit-irrigated to 80% of field capacity three to four times per week in periods without sufficient natural rainfall. Fertilizer (mean N–P–K ratio, 100–22–74) was given as completely balanced compound fertilizers every second week. Each experimental green was divided in different management levels: High and low fertilizer rate and high and low mowing. The two fertilizer rates were 10 and 17 g N m−2 yr−1 and the two mowing heights were 3 and 5 mm. Mixtures were managed at both regimes. There was no use of pesticides or plant growth regulators in any of the trials.